
IDEX (IEX) Stock Forecast & Price Target
IDEX (IEX) Analyst Ratings
Bulls say
IDEX is projected to achieve a core sales increase of 1.5% to 2% in 2026, reflecting strong order growth of 7%, particularly in sectors such as data centers, municipal water, and semiconductor maintenance, repair, and operations (MRO). The company reported organic revenue growth of 5% in 2025, surpassing estimates, driven by robust performance in the Fluid and Metering Technologies (FMT) and Health and Science Technologies (HST) segments. Positive indications for future growth are supported by anticipated increases in core sales of 3% to 4% for 2027, stemming from optimistic outlooks in niche markets including pharmaceuticals and space defense.
Bears say
IDEX exhibits a concerning financial outlook characterized by mixed organic sales and order trends across its segments, indicating potential stagnation in revenue growth. The company's gross debt/EBITDA ratio stands at 2.0x, suggesting manageable leverage, yet the persistent exposure to cyclical markets raises concerns about the sustainability of its performance in light of economic uncertainties. Additionally, projections indicate a potential cash EPS of only ~$7.61 for 2026, highlighting vulnerability to prolonged revenue declines and operating margin pressures, which could further hinder IDEX's financial stability.
This aggregate rating is based on analysts' research of IDEX and is not a guaranteed prediction by Public.com or investment advice.
IDEX (IEX) Analyst Forecast & Price Prediction
Start investing in IDEX (IEX)
Order type
Buy in
Order amount
Est. shares
0 shares